OAC
ANRO icon

OMERS Administration Corp’s Alto Neuroscience ANRO Stock Holding History

OMERS Administration Corp’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$218K Sell
9,700
-2,700
-22% -$50K ﹤0.01% 897
2025
Q4 		$221K Buy
+12,400
New +$156K ﹤0.01% 892

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

OMERS Administration Corp's ANRO Position: Q1 2026 in Review

OMERS Administration Corp reduced its Alto Neuroscience (ANRO) stake by 22% in Q1 2026, selling an estimated $50K and leaving 9,700 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #897.

OMERS Administration Corp first reported a position in ANRO in Q4 2025 and has held it in 2 quarters since. The position peaked at $221K in Q4 2025. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • OMERS Administration Corp held 9,700 shares of Alto Neuroscience worth $218K as of Q1 2026.
  • OMERS Administration Corp sold 2,700 Alto Neuroscience shares in Q1 2026, an estimated $50K.
  • Alto Neuroscience made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #897 holding.
  • OMERS Administration Corp first reported a position in Alto Neuroscience in Q4 2025 and has held it in 2 quarters since.
  • OMERS Administration Corp's Alto Neuroscience position peaked at $221K in Q4 2025.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.